As mentioned above, CD44 receptors are overexpressed on the surfaces of various tumor cells, including breast cancer [22,23] and lung cancer [12,24], therefore, CD44 can be utilized as a cancer-targeting biomarker. This evidence concerns the gene CD44 and lung carcinoma.